MKC icon

McCormick & Company Non-Voting

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 38.5%
Negative

Neutral
Zacks Investment Research
4 hours ago
Can McCormick's Innovation & Distribution Wins Offset Cost Pressures?
MKC delivers a fifth straight quarter of volume growth, using brand investment and innovation to offset cost pressures.
Can McCormick's Innovation & Distribution Wins Offset Cost Pressures?
Neutral
Seeking Alpha
11 hours ago
McCormick: A Dividend Aristocrat Priced For Perfection
McCormick is a Dividend Aristocrat that trades above intrinsic value, with a Hold rating justified by premium valuation and macro pressures not properly reflected. MKC's dividend comes with an ~80% payout ratio, currently trading at one of their highest yields, but consumer weakness and tariffs weigh on performance. Despite strategic sourcing and productivity initiatives, MKC faces intensifying competition from private labels and relies heavily on global supply chains.
McCormick: A Dividend Aristocrat Priced For Perfection
Positive
Zacks Investment Research
8 days ago
McCormick Takes Majority Control in Mexico JV: Growth Lever in 2026?
MKC boosts its Mexico presence by lifting its stake in McCormick de Mexico to 75%, gaining control and positioning the business for growth.
McCormick Takes Majority Control in Mexico JV: Growth Lever in 2026?
Positive
Seeking Alpha
11 days ago
Top 10 High-Yield Dividend Stocks For January 2026
My high-yield dividend watchlist aims for quality stocks at attractive valuations, with a long-term CAGR target of 12%. In December 2025, the watchlist gained 0.03%, outperforming VYM and SPY, though annual performance lagged benchmarks. The Quality portfolio variant has outperformed recently, with all three variants beating benchmarks over the past two months.
Top 10 High-Yield Dividend Stocks For January 2026
Positive
Seeking Alpha
11 days ago
Top 15 High-Growth Dividend Stocks For January 2026
My Top 15 High-Growth Dividend Stock list delivered a 0.83% gain in December, outperforming SPY and VIG. The Value-tilted portfolio variant led with a 2.17% December return, suggesting undervaluation may drive near-term alpha. Collectively, the January 2026 list offers a 1.35% yield, 16.87% five-year dividend growth, and appears 29% undervalued.
Top 15 High-Growth Dividend Stocks For January 2026
Neutral
PRNewsWire
11 days ago
McCormick Completes Acquisition of Controlling Interest in McCormick de Mexico
HUNT VALLEY, Md., Jan. 2, 2026 /PRNewswire/ -- McCormick & Company Inc. (NYSE: MKC) (the "Company"), a global leader in flavor, today announced that it has completed the acquisition of an additional 25% ownership interest in McCormick de Mexico from Grupo Herdez, increasing its ownership to 75%.
McCormick Completes Acquisition of Controlling Interest in McCormick de Mexico
Positive
Seeking Alpha
14 days ago
Best Dividend Aristocrats For January 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
Best Dividend Aristocrats For January 2026
Neutral
PRNewsWire
23 days ago
McCormick & Company to Report 2025 Fourth Quarter Financial Results on January 22, 2026
HUNT VALLEY, Md., Dec. 22, 2025 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE: MKC), a global leader in flavor, is scheduled to conduct a conference call and webcast of its fourth quarter 2025 financial results on Thursday January 22, 2026, at 8:00 a.m.
McCormick & Company to Report 2025 Fourth Quarter Financial Results on January 22, 2026
Neutral
CNBC Television
23 days ago
Sen. Dave McCormick on 2026 priorities, future of health care and U.S. debt problem
Sen. Dave McCormick (R-Pa.) joins 'Squawk Box' to discuss details of his 'letter to shareholders' to the people of Pennsylvania, GOP's health care plan, addressing the growing U.S. debt, taxing the rich, and more.
Sen. Dave McCormick on 2026 priorities, future of health care and U.S. debt problem
Positive
Zacks Investment Research
1 month ago
McCormick's Q3 Volumes Gain Traction: What to Expect in 2026?
MKC's volume-led momentum accelerates as consumer demand, share gains, and brand execution drive sustained growth into 2026.
McCormick's Q3 Volumes Gain Traction: What to Expect in 2026?